Despite poor growth, the company trades at a market-comparab...

Despite poor growth, the company trades at a market-comparable P/E ratio, indicating investor hopes for a business turnaround. However, continued earnings trends may lead to share price decline, risking investors paying an unnecessary premium. Three warning signs for Zhejiang Garden Biopharmaceutical Co.,Ltd. should also be considered.